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Abstract
The food enzyme is an a-amylase (4-a-D-glucan glucanohydrolase; EC 3.2.1.1), produced with the
genetically modified Aspergillus niger strain NZYM-SB by Novozymes A/S. The food enzyme does not
contain the production organism or its DNA; therefore, there is no safety concern for the environment.
The a-amylase is intended for use in starch processing, beverage alcohol (distilling) processes and
baking processes. Residual amounts of total organic solids (TOS) are removed by distillation and by the
purification steps applied during the production of glucose syrups (by > 99%). Consequently, dietary
exposure was not calculated for these two uses. Based on the maximum use levels recommended for
the baking processes and individual consumption data from the EFSA Comprehensive European Food
Consumption Database, dietary exposure to the food enzyme–TOS was estimated to be up to 3.075 mg
TOS/kg body weight per day in European populations. The food enzyme did not induce gene mutations
in bacteria or micronuclei in human lymphocytes. Subchronic toxicity was assessed by means of a
repeated-dose 90-day oral toxicity study in rodents. A no observed adverse effect level (NOAEL) was
derived that, compared with the dietary exposure, resulted in a sufficiently high margin of exposure
(MOE). Similarity of the amino acid sequence to those of known allergens was searched and two
matches were found. The Panel considered that the risk of allergic sensitisation and elicitation reactions
by dietary exposure cannot be excluded, but the likelihood is considered low. Based on the genetic
modifications, the manufacturing process, the compositional and biochemical data, the findings in the
toxicological and genotoxicity studies, as well as the estimated dietary exposure, the Panel concluded
that this food enzyme does not give rise to safety concerns under the intended conditions of use.
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of European Food Safety Authority.
Keywords: food enzyme, a-amylase, 4-a-D-glucan glucanohydrolase, EC 3.2.1.1, Aspergillus niger,





Panel members: Vittorio Silano, Claudia Bolognesi, Laurence Castle, Kevin Chipman, Jean-Pierre
Cravedi, Karl-Heinz Engel, Paul Fowler, Roland Franz, Konrad Grob, Rainer G€urtler, Trine Husøy, Sirpa
K€arenlampi, Wim Mennes, Maria Rosaria Milana, Karla Pfaff, Gilles Riviere, Jannavi Srinivasan, Maria de
Fatima Tavares Pocas, Christina Tlustos, Detlef W€olfle and Holger Zorn.
Note: The full opinion will be published in accordance with Article 12 of Regulation (EC) No. 1331/2008
once the decision on confidentiality will be received from the European Commission.
Acknowledgements: The Panel wishes to thank EFSA staff members: Jaime Aguilera, Ana Gomes,
Christine Horn, Joaquim Maia and Annamaria Rossi for the support provided to this scientific output.
Suggested citation: EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings
and Processing Aids), Silano V, Bolognesi C, Castle L, Chipman K, Cravedi J-P, Fowler P, Franz R, Grob K,
G€urtler R, Husøy T, K€arenlampi S, Mennes W, Milana MR, Pfaff K, Riviere G, Srinivasan J, Tavares Pocas MF,
Tlustos C, W€olfle D, Zorn H, Chesson A, Glandorf B, Herman L, Jany K-D, Marcon F, Penninks A, Smith A,
Van Loveren H, Zeljezic D, Aguilera-Gomez M, Andryszkiewicz M, Arcella D, Kovalkovicova N, Liu Y and
Engel K-H, 2018. Scientific Opinion on the safety evaluation of the food enzyme a-amylase from a
genetically modified Aspergillus niger (strain NZYM-SB). EFSA Journal 2018;16(7):5320, 21 pp. https://
doi.org/10.2903/j.efsa.2018.5320
ISSN: 1831-4732
© 2018 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf
of European Food Safety Authority.
This is an open access article under the terms of the Creative Commons Attribution-NoDerivs License,
which permits use and distribution in any medium, provided the original work is properly cited and no
modifications or adaptations are made.
The EFSA Journal is a publication of the European Food
Safety Authority, an agency of the European Union.
Safety of a-amylase from Aspergillus niger (NZYM-SB)




1.1. Background and Terms of Reference as provided by the requestor.................................................. 4
1.1.1. Background as provided by the European Commission ................................................................... 4
1.1.2. Terms of Reference ..................................................................................................................... 4
1.2. Interpretation of the Terms of Reference....................................................................................... 5
1.3. Information on existing authorisations and evaluations................................................................... 5




3.1. Technical data............................................................................................................................. 5
3.1.1. Identity of the food enzyme......................................................................................................... 5
3.1.2. Chemical parameters ................................................................................................................... 5
3.1.3. Properties of the food enzyme...................................................................................................... 6
3.1.4. Information of the microbial source material ................................................................................. 7
3.1.4.1. Information on the genetically modified microorganism.................................................................. 7
3.1.4.2. Characteristics of the parental and recipient microorganisms .......................................................... 7
3.1.4.3. Characteristics of introduced sequences ........................................................................................ 7
3.1.4.4. Description of the genetic modification process ............................................................................. 7
3.1.4.5. Safety aspects of the genetic modification..................................................................................... 8
3.1.5. Manufacturing process................................................................................................................. 8
3.1.6. Safety for the environment .......................................................................................................... 8
3.1.7. Case of need and intended conditions of use................................................................................. 8
3.1.8. Reaction and fate in food............................................................................................................. 9
3.2. Dietary exposure ......................................................................................................................... 9
3.2.1. EFSA Comprehensive European Food Consumption Database ......................................................... 10
3.2.2. Exposure assessment methodology............................................................................................... 10
3.2.3. Exposure to food enzyme–TOS according to the intended use proposed by the applicant.................. 10
3.2.4. Uncertainty analysis..................................................................................................................... 11
3.3. Toxicological assessment.............................................................................................................. 11
3.3.1. Genotoxicity................................................................................................................................ 12
3.3.1.1. Bacterial reverse mutation test ..................................................................................................... 12
3.3.1.2. In vitro mammalian cell micronucleus test ..................................................................................... 12
3.3.2. Repeated-dose 90-day oral toxicity study in rodents ...................................................................... 12
3.4. Allergenicity ................................................................................................................................ 13
Conclusions.............................................................................................................................................. 14
Documentation provided to EFSA .............................................................................................................. 14
References............................................................................................................................................... 14
Abbreviations ........................................................................................................................................... 16
Appendix A – Population groups considered for the exposure assessment..................................................... 17
Appendix B – FoodEx categories used to derive exposure estimates for the food enzyme–TOS and the
respective conversion factors .................................................................................................................... 18
Appendix C – Dietary exposure estimates to the food enzyme–TOS in details................................................ 21
Safety of a-amylase from Aspergillus niger (NZYM-SB)
www.efsa.europa.eu/efsajournal 3 EFSA Journal 2018;16(7):5320
1. Introduction
Article 3 of the Regulation (EC) No. 1332/20081 provides definition for ‘food enzyme’ and ‘food enzyme
preparation’.
‘Food enzyme’ means a product obtained from plants, animals or microorganisms or products
thereof including a product obtained by a fermentation process using microorganisms: (i) containing
one or more enzymes capable of catalysing a specific biochemical reaction; and (ii) added to food
for a technological purpose at any stage of the manufacturing, processing, preparation, treatment,
packaging, transport or storage of foods.
‘Food enzyme preparation’ means a formulation consisting of one or more food enzymes in which
substances such as food additives and/or other food ingredients are incorporated to facilitate their
storage, sale, standardisation, dilution or dissolution.
Before January 2009, food enzymes other than those used as food additives were not regulated or
were regulated as processing aids under the legislation of the Member States. On 20 January 2009,
Regulation (EC) No. 1332/2008 on food enzymes came into force. This Regulation applies to enzymes
that are added to food to perform a technological function in the manufacture, processing,
preparation, treatment, packaging, transport or storage of such food, including enzymes used as
processing aids. Regulation (EC) No. 1331/20082 established the European Union (EU) procedures for
the safety assessment and the authorisation procedure of food additives, food enzymes and food
flavourings. The use of a food enzyme shall be authorised only if it is demonstrated that:
• it does not pose a safety concern to the health of the consumer at the level of use proposed;
• there is a reasonable technological need;
• its use does not mislead the consumer.
All food enzymes currently on the EU market and intended to remain on that market, as well as all
new food enzymes, shall be subjected to a safety evaluation by the European Food Safety Authority
(EFSA) and approval via an EU Community list.
The ‘Guidance on submission of a dossier on food enzymes for safety evaluation’ (EFSA CEF Panel,
2009) lays down the administrative, technical and toxicological data required.
1.1. Background and Terms of Reference as provided by the requestor
1.1.1. Background as provided by the European Commission
Only food enzymes included in the Union list may be placed on the market as such and used in
foods, in accordance with the specifications and conditions of use provided for in Article 7 (2) of
Regulation (EC) No. 1332/2008 on food enzymes.
Two applications have been put forward by the company ‘Novozymes A/S’ for the authorisation of the
food enzymes serine protease (with trypsin specificity) from a genetically modified strain of
Fusarium venenatum (strain NZYM-FG) and a-amylase from a genetically modified strain of
Aspergillus niger (strain NZYM-SB).
Following the requirements of Article 12.1 of Commission Regulation (EU) No. 234/20113
implementing Regulation (EC) No. 1331/2008, the Commission has verified that the two applications
fall within the scope of the food enzyme Regulation and contain all the items required under Chapter
II of that Regulation.
1.1.2. Terms of Reference
The European Commission (EC) requests the European Food Safety Authority (EFSA) to carry out
the safety assessments on the food enzymes serine protease (with trypsin specificity) from a
genetically modified strain of Fusarium venenatum (strain NZYM-FG) and a-amylase from a genetically
1 Regulation (EC) No. 1332/2008 of the European Parliament and of the Council of 16 December 2008 on Food Enzymes and
Amending Council Directive 83/417/EEC, Council Regulation (EC) No. 1493/1999, Directive 2000/13/EC, Council Directive 2001/
112/EC and Regulation (EC) No. 258/97. OJ L 354, 31.12.2008, pp. 7–15.
2 Regulation (EC) No. 1331/2008 of the European Parliament and of the Council of 16 December 2008 establishing a common
authorisation procedure for food additives, food enzymes and food flavourings. OJ L 354, 31.12.2008, pp. 1–6.
3 Commission Regulation (EU) No. 234/2011 of 10 March 2011 implementing Regulation (EC) No. 1331/2008 of the European
Parliament and of the Council establishing a common authorisation procedure for food additives, food enzymes and food
flavourings. OJ L 64, 11.03.2011, pp. 15–24.
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modified strain of Aspergillus niger (strain NZYM-SB) in accordance with Article 17.3 of Regulation (EC)
No. 1332/2008 on food enzymes.
1.2. Interpretation of the Terms of Reference
The present scientific opinion addresses the European Commission’s request to carry out the safety
assessment of the food enzyme a-amylase from a genetically modified (GM) strain of A. niger (strain
NZYM-SB).
1.3. Information on existing authorisations and evaluations
The applicant reports that Danish and French authorities have not yet evaluated and authorised the
use of a-amylase from a GM strain of A. niger (strain NZYM-SB).
2. Data and methodologies
2.1. Data
The applicant has submitted a dossier in support of the application for authorisation of the food
enzyme a-amylase from a GM A. niger (strain NZYM-SB). The food enzyme is intended to be used in
starch processing for the production of glucose syrups, distilled alcohol production and baking processes.
2.2. Methodologies
The assessment was conducted in line with the principles described in the EFSA ‘Guidance on
transparency in the scientific aspects of risk assessment’ (EFSA, 2009) and following the relevant
existing Guidances from the EFSA Scientific Committee.
The current ‘Guidance on the submission of a dossier on food enzymes for safety evaluation’ (EFSA
CEF Panel, 2009) has been followed for the evaluation of the application with the exception of the
exposure assessment, which was carried out in accordance to the methodology described in the CEF
Panel statement on the exposure assessment of food enzymes (EFSA CEF Panel, 2016).
3. Assessment
3.1. Technical data
3.1.1. Identity of the food enzyme
IUBMB nomenclature: a-Amylase
Systematic name: 4-a-D-Glucan glucanohydrolase
Synonyms: Endo-amylase, 1,4-a-D-glucan glucanohydrolase




The a-amylase produced with the GM A. niger (strain NZYM-SB) consists of a single-polypeptide
chain of 580 amino acids. The molecular mass, derived from the amino acid sequence, was
calculated to be 63.2 kDa. The protein pattern of the food enzyme was investigated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis. The gels presented for the
four food enzyme batches are comparable, showing multiple protein bands including a band in the
63 kDa region.
The food enzyme was tested for other enzyme activities. Lipase and protease activities were below
the detection limits of the employed methods, but glucoamylase activity was detected. However, the
Panel did not consider this of being of safety concern.4
4 LODs: glucoamylase = 0.825 AGU/g; lipase = 0.02 KLU/g; protease = 196 HUT/g.
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Data on the chemical parameters of the food enzyme have been provided for four food enzyme
batches, three batches used for commercialisation and one batch used for the toxicological tests
(Table 1). The average total organic solids (TOS) content of the three commercial enzyme batches was
10.4% (w/w); the values ranged from 7.5 to 13.9% (Table 1).
The enzyme activity/mg TOS ratio of the three food enzyme batches ranged from 0.46 to 0.71
Fungal a-Amylase Units (FAU(F))/mg TOS (Table 1). The average value of 0.58 FAU(F)/mg TOS was
used for subsequent calculations.
The lead content in the three commercial batches (not more than 5 mg/kg), complies with the
specification for lead as laid down in the general specifications and considerations for enzymes used in
food processing (FAO/WHO, 2006). In addition, the levels of arsenic, cadmium and mercury were
below the limits of detection of the employed methodologies.5
No antimicrobial activity was detected in any of these batches (FAO/WHO, 2006).
Mycotoxins ochratoxin A and fumonisins are of major concern in species of A. niger (Blumenthal,
2004; Frisvad et al., 2007, 2011; EFSA, 2017). The presence of the mycotoxins ochratoxin A and
fumonisin B2 was examined in the four food enzyme batches and they were below the limits of
detection of the applied analytical methods.6
The food enzyme complies with the microbiological criteria as laid down in the general
specifications and considerations for enzymes used in food processing (FAO/WHO, 2006), which
stipulate that Escherichia coli and Salmonella species are absent in 25 g of sample and total coliforms
should not exceed 30 colony-forming units (CFU) per gram.
The applicant has provided information on the identities of the antifoam agents used. Taking into
account the nature and properties of the antifoam agents, the manufacturing process and the quality
assurance system implemented by the applicant, the Panel considers their use as of no safety concern.
The Panel considered the compositional data provided for the food enzyme as sufficient.
3.1.3. Properties of the food enzyme
The a-amylase catalyses the hydrolysis of 1,4-a-glycosidic linkages in starch (amylose and
amylopectin), resulting in the production of soluble dextrins and other malto-oligosaccharides.
The analytical principle to determine a-amylase activity is based on hydrolysis of the substrate 4,6-
ethylidene(G7)-p-nitrophenyl(G1)-a,D-maltoheptaoside, which is cleaved to glucose and p-nitrophenol
(reaction conditions: pH 7.15, temperature 37°C, reaction time 5 min). The enzymatic activity is
determined by measuring the formation of p-nitrophenol spectrophotometrically at 405 nm. The
a-amylase activity is measured relative to an internal enzyme standard and expressed in fungal a-amylase
units/g (FAU(F)/g).
The a-amylase enzyme has been characterised under different temperature and pH conditions. The
a-amylase is active at temperatures up to 80°C (with an optimum of 46–62°C at pH 5.5) and within a
pH range of 2–10 (with an optimum of about pH 3 at 30°C).
The thermostability of the a-amylase was tested over the range of 30–90°C after a pre-incubation
at the different temperatures at pH 5.5 for 30 min. The activity itself was measured at 30°C and pH
Table 1: Compositional data of the food enzyme
Parameter Unit
Batches
1 2 3 4(a)
a-Amylase activity FAU(F)/g batch(b) 63.6 55.9 53.3 53.3
Protein % 9.3 7.9 7.6 7.8
Ash % 0.4 0.9 0.8 0.7
Water % 85.7 89.4 91.7 87.6
Total organic solids (TOS)(c) % 13.9 9.7 7.5 11.7
a-Amylase activity/mg TOS FAU(F)/mg TOS 0.46 0.58 0.71 0.46
(a): Batch used for the toxicological tests.
(b): FAU(F): fungal alpha-amylase units (relative to an internal standard ‘F’) (see Section 3.1.3).
(c): TOS calculated as 100%  % water  % ash.
5 LODs: Pb = 0.5 mg/kg; As = 0.1 mg/kg; Cd = 0.05 mg/kg; Hg = 0.03 mg/kg.
6 LODs: ochratoxin A and fumonisin B2 = 0.0003 mg/kg.
Safety of a-amylase from Aspergillus niger (NZYM-SB)
www.efsa.europa.eu/efsajournal 6 EFSA Journal 2018;16(7):5320
5.5 using an insoluble blue-dyed cross-linked starch as substrate. The enzyme shows about 100%
activity up to approximately 40°C, less than 50% residual activity above 70°C and no activity remains
at 80°C after 30 min.
3.1.4. Information of the microbial source material
3.1.4.1. Information on the genetically modified microorganism
The technical dossier contains detailed information on the recipient microorganism, the donor
organism and the genetic modification process.
The a-amylase production organism A. niger NZYM-SB is deposited at the
with deposit number
3.1.4.2. Characteristics of the parental and recipient microorganisms
Some strains of A. niger have a long history of use in the production of food enzymes (Schuster
et al., 2002; van Dijck et al., 2003; Park et al., 2017).
The parental strain is A. niger The first intermediate strain
derived from the parental strain by was found not to produce
Strain
was identified as A. niger by
Recipient strain A. niger was derived from by
3.1.4.3. Characteristics of introduced sequences
3.1.4.4. Description of the genetic modification process
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3.1.4.5. Safety aspects of the genetic modification
The recipient strain A. niger differs from the parental strain
The production strain A. niger NZYM-SB differs from the recipient strain
The absence of antibiotic resistance genes used during the genetic modification was confirmed by
Phenotypic stability of the A. niger NZYM-SB strain was confirmed by
The genetic stability of the production strain A. niger NZYM-SB was demonstrated by
3.1.5. Manufacturing process
The food enzyme is manufactured according to the Food Hygiene Regulation (EC) No. 852/20047,
with food safety procedures based on Hazard Analysis and Critical Control Points (HACCP), and in
accordance with current Good Manufacturing Practice (GMP).
The food enzyme is produced by a pure culture in a contained, fermentation
system with conventional process controls in place. The identity and purity of the culture are checked
at each transfer step from frozen vials until the end of fermentation.
The food enzyme produced is recovered from the fermentation broth after biomass separation
using filtration. Further purification and concentration involve a series of filtration steps, including
and After stabilisation with
the food enzyme preparation is commercialised in a liquid or in a solid form.
The absence of the production strain in the food enzyme was demonstrated
No DNA was detected
The Panel considered the information provided on the raw materials and the manufacturing process
as sufficient.
3.1.6. Safety for the environment
The production strain and its DNA were not detected in the final product. The Panel concluded that
there is no safety concern for the environment.
3.1.7. Case of need and intended conditions of use
The original uses proposed by the applicant were starch processing for glucose syrup production,
distilled alcohol production and baking and cereal-based processes. In the course of the evaluation
process, the applicant informed EFSA about withdrawal of the intended use in cereal-based processes.
The resulting intended uses and the recommended use levels are summarised in Table 2.
7 Regulation (EC) No. 852/2004 of the European Parliament and of the Council of 29 April 2004 on the hygiene of food additives.
OJ L 226, 25.6.2004, pp. 3–21.
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In starch processing for glucose syrups production, the a-amylase is typically added during the
saccharification step when it degrades gelatinised starch into dextrins. The a-amylase can also be used
for raw starch hydrolysis where the starch is not completely gelatinised. In this case, the enzyme can be
added to the feed tank, where process conditions are adapted to the temperature and pH profile of the
enzyme.
In distilled alcohol production, the a-amylase is typically applied during the presaccharification
together with other saccharification enzymes (e.g. glucoamylase) to degrade the dextrins to
fermentable sugars. In plants using the simultaneous saccharification and fermentation (SSF) process,
liquefied mash is pumped into the fermenter, where the a-amylase and other saccharification enzymes
are added together with the yeast at the beginning of fermenter fill.
In baking processes, the food enzyme is added to the raw materials during the preparation of the
dough. The a-amylase hydrolyses starch from granules that have been damaged during the milling
and therefore releasing fermentable sugars and dextrins. These are further degraded by other
enzymes. By hydrolysing damaged starch granules, a-amylase liberates water for optimal gluten
development and improved gas retention.
3.1.8. Reaction and fate in food
The a-amylase catalyses the hydrolysis of 1,4-a-glycosidic linkages in starch (amylose and
amylopectin) resulting in the generation of dextrins and other malto-oligosaccharides.
Experimental data have been provided on the removal (> 99%) of protein in the course of distilled
alcohol production and starch processing for the production of glucose syrups (Documentation
provided to EFSA No. 5). The Panel considered the evidence as sufficient to conclude that residual
amounts of TOS (including substances other than proteins) are removed by distillation. In addition,
when taking into account the purification steps applied to the production of glucose syrups i.e.
filtration, ion exchange chromatography, treatment with active carbon, the Panel also considers that
the amount of TOS in the final glucose syrup is removed to a similar degree.
The data and the information provided indicate that the a-amylase is inactivated during the baking
processes under the intended conditions of use.
3.2. Dietary exposure
As residual amounts of TOS are removed by distillation and by the purification steps applied during
the production of glucose syrups (by > 99%), a dietary exposure to the food enzyme resulting from
these intended uses was not calculated.
For baking processes, dietary exposure estimates were calculated using the methodology described in
the CEF Panel statement on the exposure assessment of food enzymes (EFSA CEF Panel, 2016). The
assessment of the food processes covered in this opinion involved the selection of relevant food groups
and application of process and technical conversion factors (Appendix B). These input data were subject
to a stakeholder consultation through open calls8 and adjusted in accordance with feedback received.
Table 2: Intended uses and recommended use levels of the food enzyme as provided by the applicant
Food manufacturing
process(a)
Raw material Recommended dosage of the food enzyme
Starch processing for
glucose syrups production
Starch dry matter Up to 200 FAU(F)/kg of starch dry matter, corresponding to
345 mg TOS/kg starch dry matter
Distilled alcohol production Starch dry matter Up to 200 FAU(F)/kg of starch dry matter, corresponding to
345 mg TOS/kg starch dry matter
Baking processes Flour Up to 160 FAU(F)/kg of flour, corresponding to 274 mg
TOS/kg flour
(a): The description provided by the applicant has been harmonised by EFSA according to the ’EC working document describing
the food processes in which food enzymes are intended to be used’ – not yet published at the adoption of this opinion.
8 http://www.efsa.europa.eu/en/data/call/161110
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3.2.1. EFSA Comprehensive European Food Consumption Database
Since 2010, the EFSA Comprehensive European Food Consumption Database (hereafter the EFSA
Comprehensive Database9) has been populated with detailed national data on food consumption.
Competent authorities in European countries provide EFSA with data on the level of food consumption
by individual consumers, as taken from the most recent national dietary survey in their country (EFSA,
2011a).
The food consumption data gathered by EFSA were collected using different methodologies, and
thus, direct country-to-country comparisons should be made with caution. Depending on the food
category and the level of detail used in exposure calculations, uncertainties might be introduced owing
to subjects underreporting and/or misreporting of consumption amounts. Nevertheless, the EFSA
Comprehensive Database is the best available source of food consumption data across Europe.
Food consumption data from the population groups, infants, toddlers, children, adolescents, adults
and the elderly, were used for the exposure assessment. For the present assessment, food consumption
data were available from 33 different dietary surveys carried out in 19 European countries (Appendix A).
Consumption records were codified according to the standardised food classification and description
system (FoodEx) (EFSA, 2011b).
3.2.2. Exposure assessment methodology
Chronic exposure was calculated based on individual consumption data, averaged over the total
survey period, excluding surveys with only 1 day per subject. High-level exposure/intake was
calculated for only those population groups, in which the sample size was sufficiently large to allow
calculation of the 95th percentile (EFSA, 2011a).
The exposure per FoodEx category (Appendix B) was subsequently added to derive an individual
total exposure per day. Finally, these exposure estimates were averaged over the number of survey
days and normalised for individual body weight (bw), resulting in an individual average exposure/day
per kg bw for the survey period. This was carried out for all individuals in the survey and per age
class, resulting in distributions of individual average exposure per survey and age class. Based on
these distributions, the mean and 95th percentile exposures were calculated per survey for the total
population and per age class.
3.2.3. Exposure to food enzyme–TOS according to the intended use proposed by
the applicant
Exposure to the food enzyme–TOS was based on intended use and the recommended maximum
use levels of the food enzyme–TOS provided by the applicant (Section 3.1.7). Foods/ingredients
derived through distilled alcohol production and starch processing were excluded from the analysis as
the Panel considered the presence of residual amounts of TOS in distilled alcohol and glucose syrups
as negligible (see Section 3.1.8). Therefore, dietary exposure to food enzyme–TOS was calculated from
foods produced involving a baking process only.
Relevant food groups and/or individual foods were selected from the Comprehensive Database and
were assumed to always contain the food enzyme–TOS at the maximum recommended use level. This
will result in an overestimation of exposure to food enzyme–TOS.
To facilitate matching of the reported use levels for baking processes with foods identified in the
Comprehensive Database, the selected foods were disaggregated to ingredient level as appropriate
and converted into the corresponding raw material i.e. flour and malted barley/starch, via the
application of conversion factors (Appendix B). For example, consumption of 100 g of bread was
converted into an intake of 70 g flour (recipe fraction of 0.7) and then multiplied by 274 mg TOS/kg
flour (Table 2) to arrive at an exposure of 19.18 mg TOS/100 g bread.
Exposure to the food enzyme–TOS was calculated by multiplying values reported for each food
category by their respective consumption amount per kilogram of body weight (kg bw) separately for
each individual in the database. Table 3 provides an overview of the derived exposure estimates.
Average and 95th percentile exposure to the food enzyme–TOS per age class, country and survey are
reported in Appendix C – Table 1. The contribution of the food enzyme–TOS from each FoodEx
category to the total dietary exposure is indicated in Appendix C – Table 2.
9 http://www.efsa.europa.eu/en/food-consumption/comprehensive-database
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3.2.4. Uncertainty analysis
In accordance with the guidance provided in the EFSA Opinion of the Scientific Committee related
to uncertainties in dietary exposure assessment (EFSA, 2007), the following sources of uncertainties
have been considered and are summarised in Table 4.
The conservative approach applied to the exposure estimate to food enzyme–TOS, in particular,
assumptions made on the occurrence and use levels of this specific food enzyme, is likely to have led
to a considerable overestimation of the exposure.
3.3. Toxicological assessment
A battery of toxicological tests that includes bacterial gene mutation assay (Ames test), in vitro
mammalian cell micronucleus test and a repeated-dose 90-day oral toxicity study in rats has been
provided. The batch used for toxicological testing (Table 1, batch 4) was considered as suitable by the
Panel.
Table 3: Summary of estimated dietary exposure to food enzyme–TOS in six population groups
Estimated exposure (mg/kg bw per day)
Population
group
Infants Toddlers Children Adolescents Adults The elderly

































Table 4: Qualitative evaluation of the influence of uncertainties on the dietary exposure estimate




Consumption data: different methodologies/representativeness/
underreporting/misreporting/no portion size standard
+/–
Use of data from food consumption survey of a few days to estimate
long-term (chronic) exposure for high percentiles (95th percentile)
+
Possible national differences in categorisation and classification of food +/–
Model assumptions and factors
FoodEx categories included in the exposure assessment were assumed to
always contain the food enzyme–TOS
+
Exposure to food enzyme–TOS was always calculated based on the
recommended maximum use level
+
Selection of broad FoodEx categories for the exposure assessment +
Use of recipe fractions in disaggregation FoodEx categories likely to
contain the food enzyme
+/–
Use of technical factors in the exposure model +/–
+: uncertainty with potential to cause overestimation of exposure; –: uncertainty with potential to cause underestimation of exposure.
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3.3.1. Genotoxicity
3.3.1.1. Bacterial reverse mutation test
To investigate the potential of a-amylase to induce gene mutations, a bacterial reverse mutation assay
(Ames test) was performed according to Organisation for Economic Co-operation and Development
(OECD) Test Guideline 471 (OECD, 1997) and following Good Laboratory Practice (GLP), in four strains of
Salmonella Typhimurium (TA98, TA100, TA1535 and TA1537) and E. coli WP2uvrA pKM101 in the
presence and absence of metabolic activation applying the `treat and plateˊ assay. Two experiments
were carried out in triplicate plating using six different concentrations of the food enzyme (156, 313, 625,
1,250, 2,500, 5,000 lg dry matter/plate, corresponding to approximately 147, 295, 590, 1,179, 2,359,
4,718 lg TOS/plate), appropriate positive controls and sterile deionised water as a negative control. All
positive control chemicals showed a significant increase of induced revertant colony numbers, confirming
the sensitivity of the tests and the efficacy of the S9-mix. Negative and positive control values were within
the historical control ranges. No toxicity was observed at any concentration level of the test substance.
Growth stimulation measured as increased viable count was observed in some tested conditions after
treatment with the food enzyme; the increase did not result in noticeable increase in the corresponding
number of revertant colonies. On treatment with the food enzyme, the numbers of the revertant colonies
were comparable to the values observed in the vehicle control groups in any tester strain both in the
presence and absence of metabolic activation. The Panel concluded that the food enzyme a-amylase did
not induce gene mutations in the bacterial reverse mutation assay under the test conditions employed for
this study.
3.3.1.2. In vitro mammalian cell micronucleus test
The in vitro mammalian cell micronucleus test was carried out according to OECD Test Guideline 487
(OECD, 2010) and following GLP. Whole blood cultures were treated with purified water (negative
control), the food enzyme or appropriate positive controls both in the presence and absence of metabolic
activation. Based on the results obtained in a cytotoxicity-range finding test, the cells were treated with
3,000, 4,000 and 5,000 lg food enzyme/mL (corresponding to 351, 468, 585 lg TOS/mL), applying a
short-term treatment (3 h followed by 21 h of recovery) in the presence and absence of S9-mix, and a
continuous treatment (24 + 24 h of recovery) in the absence of S9-mix. No significant changes in
osmolarity and pH were detected. Two thousand cells were scored per experimental point. The positive
controls induced statistically significant increases in micronucleus frequency and the system was
considered sensitive and valid. Negative controls were within the historical vehicle control ranges. No
significant increase of cytotoxicity was observed at the highest concentration tested (4, 0 and 0% after
short-term treatment with or without S9-mix, and continuous treatment, respectively). No statistically
significant increase in the frequency of micronuclei was observed in the treated cultures compared to the
negative controls in all the tested conditions. The Panel concluded that the food enzyme a-amylase did
not induce micronuclei under the test conditions employed for this study.
The Panel concludes on the basis of the in vitro studies that there is no concern for genotoxicity for
the food enzyme tested.
3.3.2. Repeated-dose 90-day oral toxicity study in rodents
The repeated-dose 90-day oral toxicity study in rodents was performed in accordance with OECD
Test Guideline 408 (OECD, 1998) and following GLP. Groups of 10 male and 10 female Sprague–
Dawley (Crl:CD(SD)) rats received via oral gavage the food enzyme (batch 4) at dose levels of 122,
400 or 1,220 mg TOS/kg bw per day for 90 days. Controls received the vehicle (water).
One high-dose female was sacrificed for welfare reasons, necropsy showed some findings that were
not treatment related.
Group mean high-beam scores (rearing activity) for high-dose males were statistically significantly
decreased at 24 min. There was no corresponding decrease in low-beam scores (cage floor activity),
which were, in contrast, higher than those of controls for all treated males (18 min). Motor activity
scores for all treated females showed a statistically significant decrease in group mean high- and low-
beam scores at 48 min. These effects were incidental and not considered to be of safety concern.
Statistically significant increases in haematocrit (4.85%), haemoglobin concentration (4.3%) and
eosinophil counts (50%) were observed in high-dose females. These changes were considered as not
toxicologically relevant and within historical control ranges.
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No other significant effects were observed.
Overall, the Panel derived a No observed adverse effect level (NOAEL) at the high-dose level of
1,220 mg TOS/kg bw per day for both males and females.
A comparison of the NOAEL (1,220 mg TOS/kg bw per day) from the 90-day study with the derived
exposure estimates in six human population groups of 0.191–1.731 mg TOS/kg bw per day at the
mean and 0.590–3.075 mg TOS/kg bw per day at the 95th percentile, resulted in a margin of
exposure (MOE) of at least 397, indicating that there is no toxicological concern.
3.4. Allergenicity
The allergenicity assessment considers only the food enzyme and not any carrier or other excipient
which may be used in the final formulation.
The potential allergenicity of the a-amylase produced with the GM A. niger (strain NZYM-SB) was
assessed by comparing its amino acid sequence with those of known allergens according to the
scientific opinion on the assessment of allergenicity of GM plants and microorganisms and derived food
and feed of the Scientific Panel on Genetically Modified Organisms (EFSA GMO Panel, 2010). Using
higher than 35% identity in a sliding window of 80 amino acids as the criterion, two matches were
found. The matching allergens are Asp o 21, an a-amylase produced by Aspergillus oryzae and Sch c
1, a glucoamylase produced by Schizophyllum commune.
Both glucoamylase from S. commune (Toyotome et al., 2014) and a-amylase from A. oryzae
(Brisman and Belin, 1991; Quirce et al., 1992, 2002; Sander et al., 1998; Brisman, 2002) are known as
occupational respiratory allergens associated with baker’s asthma. However, several studies have
shown that adults with occupational asthma to a food enzyme (as described for a-amylase from
A. oryzae) can ingest respiratory allergens without acquiring clinical symptoms of food allergy (Cullinan
et al., 1997; Poulsen, 2004; Armentia et al., 2009). Taking into account the wide use of a-amylase as
food enzyme, only a low number of case reports has been described in literature that focused on
allergic reactions upon oral exposure to a-amylase in individuals respiratory sensitised to a-amylase
(Losada et al., 1992; Quirce et al., 1992; Baur and Czuppon, 1995; Kanny and Moneret-Vautrin, 1995;
Moreno-Ancillo et al., 2004). Such information has not been reported for glucoamylase.
No information is available on oral and respiratory sensitisation or elicitation reactions of this
a-amylase.
The Panel noted that an allergic reaction upon oral ingestion of this a-amylase produced with the
GM A. niger strain NZYM-SB, in individuals respiratory sensitised to a-amylase or to glucoamylase
cannot be ruled out, but the likelihood of such a reaction to occur is considered to be low.
According to the information provided, substances or products that may cause allergies (
) or intolerances (Regulation EU 1169/201110) are used as raw materials in the growth medium of
the production organism. However, during the fermentation, these products will be degraded and
utilised by the fungus for cell growth, cell maintenance and production of enzyme protein. In addition,
the fungal biomass and fermentation solids will be removed. Taking into account the fermentation
process and downstream processing, the Panel considered that potentially allergenic residues of these
foods employed as protein sources are not expected to be present.
Quantifying the risk for allergenicity is not possible in view of the individual susceptibility to food
allergens. Allergenicity can be ruled out only if the proteins are fully removed (e.g. in distilled alcohol
production). In the starch processing for the production of glucose syrups, although experimental data
showed a significant removal (> 99%) of protein, traces amount of protein, estimated to be about
0.5 mg/kg, could be present in glucose syrup. Products such as candy and ice creams can contain
about 50% and 40% glucose syrup, respectively, and therefore, proteins could be present in a
quantity sufficient to elicit an allergic reaction.
The Panel considers that under the intended condition of use the risk of allergic sensitisation and
elicitation reactions upon dietary exposure to this food enzyme cannot be excluded but the likelihood
of such reactions to occur is considered to be low.
10 Regulation (EU) No. 1169/2011 of the European Parliament and of the Council of 25 October 2011 on the provision of food
information to consumers, amending Regulations (EC) No. 1924/2006 and (EC) No. 1925/2006 of the European Parliament
and of the Council, and repealing Commission Directive 87/250/EEC, Council Directive 90/496/EEC, Commission Directive
1999/10/EC, Directive 2000/13/EC of the European Parliament and of the Council, Commission Directives 2002/67/EC and
2008/5/EC and Commission Regulation (EC) No. 608/2004.
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Conclusions
Based on the genetic modifications performed, the data provided on the manufacturing process,
the compositional and biochemical data provided, the dietary exposure assessment as well as the
findings in the toxicological studies, the Panel concludes that the food enzyme a-amylase produced
with the GM A. niger (strain NZYM-SB) by Novozymes A/S does not give rise to safety concerns under
the intended conditions of use.
Regarding the allergenicity assessment, the risk of allergic sensitisation and elicitation reactions
upon dietary exposure to this food enzyme cannot be excluded, but the likelihood of such reaction can
be considered to be low.
Documentation provided to EFSA
1) Dossier ‘Application for authorisation of a-amylase produced by a genetically modified strain
of Aspergillus niger (strain NZYM-SB)’. 15 May 2014. Submitted by Novozymes A/S.
2) Summary report on toxicological data for a-amylase produced by a genetically modified
strain of Aspergillus niger (strain NZYM-SB). Delivered by FoBiG GmbH (Freiburg, Germany)
on 3 December 2014.
3) Additional information received by 5 October 2017. Submitted by Novozymes A/S.
4) Additional information received by 22 February 2018. Submitted by Novozymes A/S.
5) AMFEP (Association of Manufacturers and Formulators of Enzyme Products), 2017. `Food
enzyme removal during the production of cereal based distilled alcoholic beverages’ and
‘Food enzyme carry-over in glucose syrups’. 22 February 2017. Unpublished document.
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Abbreviations
AMFEP Association of Manufacturers and Formulators of Enzyme Products
bp a base pair
bw body weight
CAS Chemical Abstracts Service
CEF EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids
CFU Colony-forming units
EINECS European Inventory of Existing Commercial Chemical Substances
FAO Food and Agricultural Organization of the United Nations
FAU(F) Fungal a-amylase units (F standard)
FoodEx A standardised food classification and description system
FOA 5-Fluoro-orotic acid
GLP Good laboratory practice
GM Genetically modified
GMO Genetically modified organisms
GMP Good manufacturing practice
HACCP Hazard Analysis and Critical Control Points
IUBMB International Union of Biochemistry and Molecular Biology
kDa kiloDalton
MOE Margin of exposure
NOAEL No observed adverse effect level
OECD Organisation for Economic Cooperation and Development
PCR Polymerase chain reaction
S9 Metabolic activation
SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
SSF Simultaneous Saccharification and Fermentation
TOS Total organic solids
WHO World Health Organisation
w/w weight for weight
Safety of a-amylase from Aspergillus niger (NZYM-SB)
www.efsa.europa.eu/efsajournal 16 EFSA Journal 2018;16(7):5320
Appendix A – Population groups considered for the exposure assessment
Population Age range
Countries with food consumption surveys covering more
than one day
Infants From 12 weeks on up to and
including 11 months of age
Bulgaria, Denmark, Finland, Germany, Italy, United Kingdom
Toddlers From 12 months up to and
including 35 months of age
Belgium, Bulgaria, Denmark, Finland, Germany, Italy,
Netherlands, Spain, United Kingdom
Children(a) From 36 months up to and
including 9 years of age
Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland,
France, Germany, Greece, Italy, Latvia, Netherlands, Spain,
Sweden, United Kingdom
Adolescents From 10 years up to and
including 17 years of age
Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland,
France, Germany, Italy, Latvia, Spain, Sweden, United Kingdom
Adults From 18 years up to and
including 64 years of age
Austria, Belgium, Czech Republic, Denmark, Finland, France,
Germany, Hungary, Ireland, Italy, Latvia, Netherlands, Romania,
Spain, Sweden, United Kingdom
The elderly(a) From 65 years of age and
older
Austria, Belgium, Denmark, Finland, France, Germany, Hungary,
Ireland, Italy, Romania, Sweden, United Kingdom
(a): The terms ‘children’ and ‘the elderly’ correspond, respectively, to ‘other children’ and the merge of ‘elderly’ and ‘very elderly’
in the Guidance of EFSA on the’ Use of the EFSA Comprehensive European Food Consumption Database in Exposure
Assessment’ (EFSA, 2011a).
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Appendix B – FoodEx categories used to derive exposure estimates for the
food enzyme–TOS and the respective conversion factors









A.01 Grains and grain-based products
(unspecified)
0.8 1 274
A.01.03 Grain milling products (unspecified) 1 1 274
A.01.03.001 Wheat milling products (unspecified) 1 1 274
A.01.03.001.001 Wheat flour, brown 1 1 274
A.01.03.001.002 Wheat flour, Durum 1 1 274
A.01.03.001.003 Wheat flour, white 1 1 274
A.01.03.001.004 Wheat flour, wholemeal 1 1 274
A.01.03.001.005 Graham flour 1 1 274
A.01.03.001.006 Wheat flour, gluten free 1 1 274
A.01.03.001.014 Wheat starch 1.2 1 274
A.01.03.002 Rye milling products (unspecified) 1 1 274
A.01.03.002.001 Rye flour, gluten free 1 1 274
A.01.03.002.002 Rye flour, light 1 1 274
A.01.03.002.003 Rye flour, medium 1 1 274
A.01.03.002.004 Rye flour, wholemeal 1 1 274
A.01.03.003 Buckwheat milling products
(unspecified)
1 1 274
A.01.03.003.001 Buckwheat flour 1 1 274
A.01.03.004 Corn milling products (unspecified) 1 1 274
A.01.03.004.001 Corn flour 1 1 274
A.01.03.004.003 Corn starch 1.3 1 274
A.01.03.005 Oat milling products (unspecified) 1 1 274
A.01.03.005.002 Oat flour 1 1 274
A.01.03.005.004 Oat starch 1.2 1 274
A.01.03.006 Rice milling products (unspecified) 1 1 274
A.01.03.006.001 Rice flour 1 1 274
A.01.03.006.002 Rice flour white 1 1 274
A.01.03.006.003 Rice flour, instant 1 1 274
A.01.03.006.004 Rice starch 1.2 1 274
A.01.03.007 Spelt milling products 1 1 274
A.01.03.008 Other milling products (unspecified) 1 1 274
A.01.03.008.001 Amaranth flour 1 1 274
A.01.03.008.002 Barley flour 1 1 274
A.01.03.008.003 Chapatti flour 1 1 274
A.01.03.008.004 Flour mix, wheat/rye/barley/oats 1 1 274
A.01.03.008.005 Millet flour 1 1 274
A.01.03.008.007 Sorghum flour 1 1 274
A.01.04 Bread and rolls (unspecified) 1 0.7 274
A.01.04.001 Wheat bread and rolls 1 0.7 274
A.01.04.002 Rye bread and rolls 1 0.7 274
A.01.04.003 Mixed wheat and rye bread and rolls 1 0.7 274
A.01.04.004 Multigrain bread and rolls 1 0.7 274
A.01.04.005 Unleavened bread, crisp bread and
rusk (unspecified)
1 0.8 274
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A.01.04.005.001 Crisp bread, rye wholemeal 1 0.9 274
A.01.04.005.002 Crisp bread, rye, light 1 0.9 274
A.01.04.005.003 Crisp bread, wheat, wholemeal 1 0.9 274
A.01.04.005.004 Crisp bread, wheat, light 1 0.9 274
A.01.04.005.005 Rusk, light 1 0.9 274
A.01.04.005.006 Rusk, wholemeal 1 0.9 274
A.01.04.005.007 Pita bread 1 0.7 274
A.01.04.005.008 Matzo 1 0.9 274
A.01.04.005.009 Tortilla 1 0.7 274
A.01.04.006 Other bread 1 0.7 274
A.01.04.007 Bread products 1 0.7 274
A.01.07 Fine bakery wares (unspecified) 1 0.5 274
A.01.07.001 Pastries and cakes (unspecified) 1 0.5 274
A.01.07.001.001 Beignets 1 0.15 274
A.01.07.001.002 Buns 1 0.7 274
A.01.07.001.003 Cake from batter 1 0.25 274
A.01.07.001.004 Cheese cream cake 1 0.24 274
A.01.07.001.005 Cheese cream sponge cake 1 0.24 274
A.01.07.001.006 Chocolate cake 1 0.24 274
A.01.07.001.007 Chocolate cake with fruits 1 0.24 274
A.01.07.001.008 Cream cake 1 0.24 274
A.01.07.001.009 Cream cheese cake 1 0.24 274
A.01.07.001.010 Cream custard cake 1 0.24 274
A.01.07.001.011 Cream custard sponge cake 1 0.24 274
A.01.07.001.012 Croissant 1 0.5 274
A.01.07.001.013 Croissant, filled with chocolate 1 0.5 274
A.01.07.001.014 Croissant, filled with cream 1 0.5 274
A.01.07.001.015 Croissant, filled with jam 1 0.5 274
A.01.07.001.016 Croquembouche 1 0.15 274
A.01.07.001.017 Doughnuts 1 0.24 274
A.01.07.001.018 Clair 1 0.15 274
A.01.07.001.019 Flan 1 0.5 274
A.01.07.001.020 Fruit cake 1 0.6 274
A.01.07.001.021 Fruit pie 1 0.15 274
A.01.07.001.022 Cheese pie 1 0.15 274
A.01.07.001.023 Fruit tart 1 0.15 274
A.01.07.001.024 Gingerbread 1 0.6 274
A.01.07.001.025 Gougere 1 0.15 274
A.01.07.001.026 Kringles 1 0.25 274
A.01.07.001.027 Nut cream cake 1 0.24 274
A.01.07.001.028 Pancakes 1 0.25 274
A.01.07.001.029 Profiterole 1 0.15 274
A.01.07.001.030 Pyramid cake 1 0.25 274
A.01.07.001.031 Rhubarb flan 1 0.15 274
A.01.07.001.032 Scone 1 0.5 274
A.01.07.001.033 Sponge dough 1 0.25 274
A.01.07.001.034 Sponge cake 1 0.25 274
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A.01.07.001.035 Sponge cake roll 1 0.25 274
A.01.07.001.036 Muffins 1 0.25 274
A.01.07.001.037 Waffles 1 0.25 274
A.01.07.001.038 Apple strudel 1 0.15 274
A.01.07.001.039 Cream-cheese strudel 1 0.24 274
A.01.07.001.040 Cheese pastry goods from puff pastry 1 0.15 274
A.01.07.001.041 Croissant from puff pastry 1 0.6 274
A.01.07.001.042 Brioche 1 0.5 274
A.01.07.001.044 Lebke 1 0.6 274
A.01.07.001.045 Dumpling 1 0.5 274
A.01.07.001.046 Cake marbled, with chocolate 1 0.5 274
A.01.07.001.047 Marzipan pie 1 0.25 274
A.01.07.001.048 Baklava 1 0.15 274
A.01.07.002 Biscuits (cookies) 1 0.9 274
A.01.07.002.001 Biscuits, sweet, plain 1 0.9 274
A.01.07.002.002 Biscuits, chocolate filling 1 0.81 274
A.01.07.002.003 Biscuits, cream filling 1 0.81 274
A.01.07.002.004 Biscuits, fruit filling 1 0.81 274
A.01.07.002.005 Biscuits, vanilla filling 1 0.81 274
A.01.07.002.006 Butter biscuits 1 0.81 274
A.01.07.002.007 Biscuit, iced 1 0.81 274
A.01.07.002.008 Speculaas 1 0.9 274
A.01.07.002.009 Biscuits, sweet, wheat wholemeal 1 0.9 274
A.01.07.002.010 Biscuits, oat meal 1 0.9 274
A.01.07.002.011 Biscuits, spelt meal 1 0.9 274
A.01.07.002.012 Biscuits, salty 1 0.9 274
A.01.07.002.013 Biscuits, salty, with cheese 1 0.81 274
A.01.07.002.014 Sticks, salty 1 0.81 274
A.17.03.003 Biscuits, rusks and cookies for
children
1 0.9 274
A.18.04.001 Find bakery products for diabetics 1 0.5 274
A.19.01.001 Sandwich and sandwich-like meal 1 0.32 274
A.19.01.002 Pizza and pizza-like pies 1 0.3 274
FoodEx: A standardised food classification and description system; TOS: total organic solids.
(a): Available online: http://www.fao.org/fileadmin/templates/ess/documents/methodology/tcf.pdf (FAO, 2000)
(b): Derived from publically available recipe information, and/or food label information (such as Mintel Global New Products
Database: http://www.mintel.com/global-new-products-database).
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Appendix C – Dietary exposure estimates to the food enzyme–TOS in
details
Information provided in this appendix is shown in an excel file (downloadable http://onlinelibrary.
wiley.com/wol1/doi/10.2903/j.efsa.2018.5320/suppinfo). The file contains two sheets, corresponding to
two tables.
Table 1: Average and 95th percentile exposure to the food enzyme–TOS per age class, country
and survey
Table 2: The contribution of the food enzyme–TOS from each FoodEx category to the total dietary
exposure
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